International Journal of Diabetes and Endocrinology

Volume 1, Issue 1, December 2016

  • Contemporary Problems of Cardiovascular Disorders at Diabetes Mellitus

    Maxim Mamalyga

    Issue: Volume 1, Issue 1, December 2016
    Pages: 1-7
    Received: Oct. 17, 2016
    Accepted: Nov. 16, 2016
    Published: Dec. 17, 2016
    DOI: 10.11648/j.ijde.20160101.11
    Downloads:
    Views:
    Abstract: At the present time, the number of patients with comorbid cardiometabolic dysfunctions, which cause more early onsets of cardiovascular diseases (CVD) and their quick progressions, has increased. Results of studies permit to suggest that such high comorbidity of cardiovascular diseases and diabetes mellitus (DM) are caused by commonness of pathogen... Show More
  • Evaluation the Effect of Glyburide and/or Metformin on Testosterone Levels in Men Patients with Type 2 Diabetes Mellitus

    Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Salah A. Al-Windy

    Issue: Volume 1, Issue 1, December 2016
    Pages: 8-12
    Received: Nov. 04, 2016
    Accepted: Dec. 02, 2016
    Published: Dec. 27, 2016
    DOI: 10.11648/j.ijde.20160101.12
    Downloads:
    Views:
    Abstract: Low testosterone serum levels have been linked with pathogenesis of type 2DM. Type 2DM pharmacotherapy may also affect the testosterone levels since; metformin decreases testosterone levels, whereas glyburide might increase the testosterone levels. Sixty-one men patients with type 2DM were selected: 22 of patients were treated with metformin, 20 of... Show More
  • Safety of the DPP-4 Inhibitor, α-glucosidase Inhibitors, Glitazones and SGLT-2 Inhibitors as Add-on Therapy with Metformin in Medication of Type 2 Diabetes Mellitus

    Alok Raghav, Jamal Ahmad, Maaz Ozair, Saba Noor, Zeeshan Ahmad Khan, Brijesh Kumar Mishra

    Issue: Volume 1, Issue 1, December 2016
    Pages: 13-15
    Received: Nov. 02, 2016
    Accepted: Dec. 29, 2016
    Published: Jan. 23, 2017
    DOI: 10.11648/j.ijde.20160101.13
    Downloads:
    Views:
    Abstract: Optimal successful management of type 2 diabetes mellitus (T2DM) remains an elusive goal ever. Add on therapies with metformin addressing the prime impaired insulin secretion shows promise in achieving strict and effective glycemic control. The aim of this study was to assess the efficacy of DPP-4 inhibitors, α-glucosidase inhibitors, glitazones an... Show More